Breaking down barriers with new Edanz partnership

BioMed
Central has announced a new agreement with Edanz, a leading medical and
scientific editing service provider, to provide researchers with cost-effective
and comprehensive English language support throughout the peer review process.
As part of this agreement, BioMed Central authors will be eligible to receive a
discount on Edanz’s services.

This
agreement will significantly improve the publishing experience of BioMed
Central authors worldwide, allowing them to obtain English language assistance
wherever they need it.

Edanz’s
services are provided by expert scientists and will support authors through
manuscript submission, peer-review,addressing reviewers’ comments, as well as
assistance with writing cover letters and advising on the most appropriate
journal for their papers. In addition, Edanz will be providing free workshops
and training materials for BioMed Central authors concentrating on how to write
a scientific manuscript. This training program will initially begin in China
and Japan but will later expand to other important regions.

Deborah
Kahn, BioMed Central Publishing Director, said, “our relationship with Edanz
will offer authors submitting to our journals a complete, rounded English
language service. The number of papers submitted to us from China alone has grown
168% in the past two years, so working with Edanz will provide greater value to
authors from this region as well as ensuring their papers meet the linguistic
demands for publication.”

Kerry
Greer, President of Edanz, said of the relationship, “both BioMed Central and Edanz are committed to further integrating scientists
from East Asia and the developing world into the global research community.
With many authors finding that language is a barrier to publication success,
this relationship provides authors an opportunity to have an experienced
native-English scientist raise the language of their paper to the international
standard needed for acceptance. We look forward to helping BioMed Central
authors worldwide reach their publication goals.”

View the latest posts on the BioMed Central blog homepage

Comments

By commenting, you’re agreeing to follow our community guidelines.

Your email address will not be published. Required fields are marked *